<DOC>
	<DOCNO>NCT02660684</DOCNO>
	<brief_summary>The objective study assess safety efficacy Tacrolimus ( Prograf capsule , Prograf injection ) Methotrexate combination therapy GVHD prophylaxis patient receive peripheral hematopoietic stem cell transplantation sibling donor , compare data historical control group administer conventional Cyclosporine formulation .</brief_summary>
	<brief_title>Study Assess Safety Efficacy Tacrolimus ( Prograf Capsule/Injection ) Methotrexate ( MTX ) Combination Therapy Prevention Graft Versus Host Disease ( GVHD ) Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From Sibling Donor</brief_title>
	<detailed_description />
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Blood diseases standard risk group Primary remission AML ( acute myeloid leukemia ) Primary remission ALL ( acute lymphocytic leukemia ) Secondary remission ALL ( acute lymphocytic leukemia ) SAA ( severe aplastic anemia ) Chronic stage CML ( chronic myeloid leukemia ) MDS ( myelodysplastic syndrome ) Myeloma ( multiple myeloma ) A patient receive peripheral hematopoietic stem cell transplantation HLAmatched sibling donor A patient renal impairment ( serum creatinine level ≥ 1.5mg/dl 130μmol/l , GFR≤ 30 % ) A pregnant breastfeeding woman A woman unwilling unable practice appropriate contraception study A patient highly likely experience aggravation treatment due active tuberculosis , hepatic disease , hypertension , heart failure , chronic obstructive respiratory disease , etc . A patient hypersensitivity tacrolimus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Prograf</keyword>
	<keyword>Graft versus host disease</keyword>
	<keyword>Hematopoietic stem cell transplantation</keyword>
	<keyword>Prophylaxis</keyword>
	<keyword>Peripheral hematopoietic stem cell transplantation</keyword>
</DOC>